Acapella® versus 'usual airway clearance' during acute exacerbation in bronchiectasis: A randomized crossover trial

Chronic Respiratory Disease

Volumn 4, Issue 2, 2007, Pages 67-74

  Patterson, J E ^a   Hewitt, O ^a   Kent, L ^a   Bradbury, I ^a   Elborn, J S ^a   Bradley, Judy M ^a,b  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Acapella ; Airway clearance techniques; Bronchiectasis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ANTIINFECTIVE AGENT;

ADULT; AIRWAY CLEARANCE DEVICE; ANTIBIOTIC THERAPY; ARTICLE; BREATHING EXERCISE; BRONCHIECTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEMOGRAPHY; DEVICE; DISEASE EXACERBATION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTERMETHOD COMPARISON; LUNG CLEARANCE; LUNG FUNCTION; MALE; PRIORITY JOURNAL; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; SPUTUM; TREATMENT DURATION; TREATMENT OUTCOME; AGED; ARTIFICIAL VENTILATION; CHEST WALL OSCILLATION; COMPARATIVE STUDY; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; MUCOCILIARY CLEARANCE; POSITIVE END EXPIRATORY PRESSURE;

AGED; ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; CHEST WALL OSCILLATION; CROSS-OVER STUDIES; HUMANS; MIDDLE AGED; MUCOCILIARY CLEARANCE; POSITIVE-PRESSURE RESPIRATION; RESPIRATORY THERAPY; SPUTUM;

EID: 34547215727     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972306075483     Document Type: Article

References (15)

1. Silverman E, Ebright L, Kwiatkowski M, Cullina J. Current management of bronchiectasis: review and 3 case studies. Lung 2003; 32: 59-64.
2. Evans DJ, Greenstone M. Long-term antibiotics in the management of non-CF bronchiectasis - do they improve outcome? Respir Med 2003; 97: 851-858.
3. O'Neill B, Bradley JM, McCardle N, MacMahon J. The current physiotherapy management of patients with bronchiectasis: a UK survey. Int J Clin Pract 2002; 56: 34-35.
4. Thompson CS, Harrison S, Ashley J, Day K, Smith DL. Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis. Thorax 2002; 57: 446-448.
5. Patterson JE, Bradley JM, Hewitt O, Bradbury I, Elborn JS. Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques (ACBT) versus Acapella®. Respiration 2005; 72: 239-242.
6. Pryor JA. Physical therapy for adults with bronchiectasis. Clin Pulm Med 2004; 11: 201-209.
7. Patterson JE, Bradley JM, Elborn JS. Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques (incorporating postural drainage and vibration) versus test of incremental respiratory endurance. Chron Respir Dis 2004; 1: 127-130.
8. Ramsey BW, Pepe M, Williams WJ. Pulmonary exacerbation (PE): How do we define it? Pediatr Pulmonol 1994; 9 (Suppl): 77-78.
9. Prasad SA, Randall SD, Balfour-Lynn IM. Fifteen-count breathlessness score: an objective measure for children. Pediatr Pulmonol 2000; 30: 56-62.
10. Falk M, Andersen JB. Positive expiratory presseure (PEP) mask. In Pryor JA ed. Respiratory care. Churchill Livingstone, 1991: 51-63.
11. Falk M, Kelstrup M, Andersen JB, Kinoshita T, Falk P, Stovring S, Gothgen I. Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis. Eur J Respir Dis 1984; 65: 423-432.
12. Volsko TA, DiFore JM, Chatburn RL. Performance comparison of two oscillating positive expiratory pressure devices: Acapella® versus Flutter. Respir Care 2003; 48: 124-130.
13. Watt AP, Brown V, Courtney J et al. Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis. Thorax 59: 23-26.
14. Van der Schans CP, Postma DS, Koeter GH, Rubin BK. Physiotherapy and bronchial mucus transport. Euro Respir J 1999; 13: 1477-1486.
15. Wilson MJB, Martin DE. Quantitative sputum culture as a means of excluding false positive reports in the routine microbiology laboratory. J Clin Path 1972; 25: 697-700.